Skip to main content
. 2022 Oct 20;11:225. doi: 10.1186/s13643-022-02044-w

Table 4.

Final set of benefit and harm outcomes deemed to be of critical or important for guideline development and decision-making

Outcome Consideration of the benefits/harms associated with the preventive health care intervention Priority
All-cause mortality

• Potential benefit (reduction in)

• Potential harm (increase in)

Critical
Hospitalization

• Potential benefit (reduction in)

• Potential harm (increase in)

Critical
Non-serious (i.e., not requiring hospitalization and not causing death) adverse drug reactions including those related to withdrawal or stopping medication

• Potential benefit (reduction in)

• Potential harm (increase in)

Critical
Quality of life

• Potential benefit (increase in)

• Potential harm (reduction in)

Important
Emergency department visits

• Potential benefit (reduction in)

• Potential harm (increase in)

Important
Injurious falls

• Potential benefit (reduction in)

• Potential harm (increase in)

Important
Medical visits

• Potential benefit (reduction in)

• Potential harm (increase in)

Important
Number of medications (and number of pills) • Potential benefit only (reduction in) Important